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As a GP working in both your own practice and the local emergency department, you commonly assess and treat patients of all ages with infections of the skin. 
The case
Late one evening, a middle-aged man limps into the emergency 
department. You note that he is pale and does not look well.  His 
left leg is extremely erythematous. You immediately admit him 
to a bed in the emergency department. His blood pressure is 
80/40 mmHg, heart rate 150 beats/minute and irregularly 
irregular, respiratory rate 28 breaths/minute and temperature 
39.2oC. 
You assess the patient and quickly note he has sepsis from a 
skin source. While you take a history, you insert an intravenous 
cannula and prescribe a one litre bolus of normal saline. You 
take samples for a full blood count, venous blood gas, electrolytes 
and creatinine measurements and blood cultures. The patient 
has no allergies and after brief history-taking you prescribe 
flucloxacillin empirically. 
The history
You learn that the patient has had recurrent episodes of cellulitis 
over the past 20 years. He has a history of chronic venous insuf-
ficiency, obesity, hypertension, type 2 diabetes and obstructive 
sleep apnoea. He states he has been treated three times in the 
past year for cellulitis and has tried compression bandaging for 
his venous insufficiency but could not tolerate this. He has no 
history of deep venous thrombosis (DVT). He reports increasing 
erythema in his left leg over the past three days, starting at the 
foot and spreading to the knee. This is very painful. 
His regular medications include perindopril and metformin 
and he uses continuous positive airway pressure (CPAP) to treat 
obstructive sleep apnoea. He has no history of immunosuppres-
sion, and his family history is unremarkable. 
Physical examination
You note that both the patient’s legs show changes consistent 
with chronic venous insufficiency, with haemosiderin deposition 
and peripheral oedema to the mid-calf. His left leg is extremely 
erythematous up to the knee. His dorsalis pedis and posterior 
tibial arteries are palpable bilaterally, and his leg is diffusely 
tender. There are no ulcers and no crepitus. You consider whether 
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A middle-aged man presents with an extremely 
painful swollen red leg and signs of sepsis. He has 
a history of chronic venous insufficiency, obesity, 
diabetes, hypertension and obstructive sleep 
apnoea. What are your differential diagnoses and 
how should he be managed?
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this is cellulitis, necrotising fasciitis or a 
DVT. The patient has a full range of move-
ment in his ankle and knee without ten-
derness, making septic arthritis less likely. 
Results of the remainder of the exam-
ination are unremarkable. 
Provisional diagnosis and 
management
When the patient’s venous blood gas 
results are returned, they show a pH of 
7.33 and a lactate level of 3.5 mmol/L. The 
creatinine level is elevated at 150 µmol/L. 
An ECG shows that he has atrial fibrilla-
tion with a rapid ventricular response at 
130 beats/minute. His blood pressure 
remains 80/40 mmHg despite the admin-
istration of one litre of fluid. 
As the patient’s leg is extremely tender, 
his blood pressure is not responsive to 
fluid and he has acute kidney injury, you 
consider necrotising fasciitis and toxic 
shock syndrome as possible diagnoses. 
Necrotising soft tissue infections are 
extremely serious and associated with 
high mortality. Consequently you pre-
scribe meropenem, clindamycin and 
 vancomycin, and request early surgical 
review.1 You also prescribe another litre 
bolus of normal saline and call the high 
dependency unit (HDU) to request the 
patient be assessed for admission. 
On completion of the second intra-
venous fluid bolus, the patient’s blood 
pressure has improved to 88/45 mmHg, 
but he remains tachycardic with a heart 
rate of 120 beats/minute. You request 
another 500 mL of intravenous normal 
saline to be given as a bolus and order a 
CT scan of the left lower limb. 
The patient’s vital signs continue to 
improve and the pain in his leg is gradu-
ally decreasing. After the 500 mL fluid 
bolus, his blood pressure has risen to 
100/60  mmHg and his heart rate is 
95 beats/minute. You prescribe another 
500 mL of normal saline to be given at a 
rate of 125 mL/h and continue to monitor 
his blood pressure closely.
The CT scan does not show any fea-
tures suggesting a necrotic infection (such 
as gas in the deep tissues) and no abscess 
or myositis, but there is significant 
 subcutaneous oedema.2 There is no 
 disruption of the bone cortex to suggest 
underlying osteomyelitis. 
Over the next two hours, the leg pain 
improves. A surgeon reviews the patient 
and deems he does not require urgent 
surgery at present given his clinical 
response but is happy to reassess him at 
TABLE 1. SKIN AND SOFT TISSUE INFECTIONS AND THEIR TREATMENT1,3
Infection Extent Treatment
Erysipelas Infection involving more superficial dermal 
structures, distinguished clinically by a clear 
border between infected and uninfected skin
Antibiotics
Cellulitis Infection of dermis and subcutaneous tissue Antibiotics
Abscess A collection in the soft tissues Incision and 
drainage ± 
antibiotics
Necrotising soft 
tissue infections
A necrotising infection that involves any soft 
tissue layer and can be as deep as the 
muscle
Debridement and 
antibiotics ± 
hyperbaric therapy
TABLE 2. SPECIFIC CIRCUMSTANCES AND THEIR EFFECT ON EMPIRIC 
ANTIMICROBIAL CHOICES FOR SKIN AND SOFT TISSUE INFECTIONS1,6 
Circumstance Considerations and typical 
organisms
Consider (always consult 
local guidelines and consider 
allergies)
Hypersensitivity to 
penicillin (non-immediate)
NA Cefalexin or cefazolin
Hypersensitivity to 
penicillin (immediate)
NA Vancomycin or clindamycin
Suspected MRSA or  
community-associated 
MRSA
MRSA Consider vancomycin or 
clindamycin (assess 
sensitivities)
Freshwater exposure Aeromonas spp. Add ciprofloxacin 
Saltwater exposure Vibrio spp. Add doxycycline 
Chronic diabetic foot 
infection
Polymicrobial Amoxicillin + clavulanate or 
piperacillin + tazobactam  
(if limb or life threatening)
Animal bites Polymicrobial Amoxicillin + clavulanate or 
piperacillin + tazobactam  
(if severe)
Necrotising soft tissue 
infection
Monomicrobial 
(Streptococcus pyogenes, 
Clostridium perfringens, 
Staphylococcus aureus, 
Vibrio spp., Aeromonas 
spp.) or polymicrobial
Meropenem + vancomycin + 
clindamycin
Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; NA = not applicable.
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any time if his condition deteriorates. The 
HDU registrar reviews the patient and 
accepts him for observation. Empirical 
treatment with meropenem, clindamycin 
and vancomycin is continued. 
Discussion
There is a wide spectrum of skin and soft 
tissue infections, and your patient high-
lights some of the concerns prompted 
by a presentation with apparent cellulitis 
and sepsis. Establishing the extent and 
depth of infection can help guide treat-
ment (Table 1).3 The incidence of DVT 
in patients presenting with cellulitis 
and no other risk factors is low, and 
routine screening by Doppler ultra-
sound examination is not generally 
recommended.4 
A wide range of organisms can cause 
cellulitis, the most common of which are 
Streptococcus species and Staphylococcus 
aureus.5 Australian guidelines recom-
mend empiric treatment with flucloxacil-
lin monotherapy.1 Additional or alterna-
tive agents may be required in specific 
circumstances (Table 2).1,6 
Your patient had sepsis and features 
suggestive of necrotising fasciitis as well 
as toxic shock syndrome early in the pres-
entation (Box 1).1,7 However, he responded 
quickly to antibiotic treatment, and his 
blood pressure eventually improved with 
fluid administration, making the latter 
two diagnoses less likely. Necrotising fas-
ciitis and toxic shock syndrome are med-
ical emergencies, and the benchmark 
treatment is early surgical debridement 
and antibiotics. Intravenous immuno-
globulin may also be considered in 
patients with toxic shock syndrome, and 
hyperbaric oxygen may be considered 
in  those with necrotising soft tissue 
infections.1
Progress 
The patient is admitted to hospital. He 
remains normotensive, the atrial fibrilla-
tion spontaneously reverts and the left leg 
erythema becomes less prominent and 
reduces in extent over the next 48 hours. 
His fever also settles. Relevant investiga-
tion results are listed in Table 3 and show 
prominent neutrophilia and an acute 
 kidney injury. These resolve over the 
course of the admission.
Results of blood cultures taken at 
 presentation show Streptococcus pyogenes 
(Group A streptococcus) that is sensitive 
to penicillin and clindamycin. Subsequent 
blood cultures have negative results, 
demonstrating quick clearance. The 
patient’s antibiotic treatment is changed 
to benzylpenicillin and clindamycin on 
day 2 and he continues to make clinical 
improvement. Research suggests clinda-
mycin decreases mortality in patients 
presenting with invasive group A strepto-
coccus infection.8
Outcome 
After seven days of antibiotic treatment, 
your patient is much improved and the 
cellulitis has completely resolved. In 
1. CLINICAL FEATURES SUGGESTING 
SEPSIS, NECROTISING SOFT TISSUE 
INFECTION OR TOXIC SHOCK 
SYNDROME1,7 
Sepsis
• Infection with features that may 
include:
 – fever
 – hypothermia
 – tachycardia
 – tachypnoea
 – hypotension
 – altered conscious state
 – elevated white cell count
Necrotising soft tissue infection 
• Severe pain and tenderness
• Skin necrosis or bleeding into  
the skin
• Bullae or vesicles
• Crepitus
• Systemic toxicity
• Rapid spread 
• Oedema or tenderness extending 
beyond the erythema
• Cutaneous anaesthesia
Toxic shock syndrome 
• Isolation of Streptococcus pyogenes,* 
hypotension unresponsive to fluid 
administration and two of:
 – acute kidney injury 
 – acute respiratory distress 
syndrome
 – coagulopathy
 – hyperbilirubinaemia
 – generalised rash or soft tissue 
necrosis
* Can also be caused by Staphylococcus aureus 
(case definition differs).
TABLE 3. RELEVANT CLINICAL CHEMISTRY AND FULL BLOOD COUNT RESULTS IN  
A PATIENT WITH CELLULITIS
Test Test result Normal range
Haemoglobin (g/L) 150 ≥130
Platelets (x 109/L) 437 150 to 400
White cell count (x 109/L) 25.2 4.5 to 11.0
Neutrophil count (x 109/L) 19.1 2.0 to 7.5
Potassium (mmol/L) 3.8 3.5 to 5.2
Sodium (mmol/L) 146 135 to 145
Urea (mmol/L) 13.8 3.0 to 8.0
Creatinine (µmol/L) 150 60 to 110
International normalised ratio 1.0 <1.1
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uncomplicated cases of cellulitis, five to 
10 days of antibiotic treatment is generally 
sufficient, but up to 14 days may be needed 
in severe cases.1,5
You consider preventing future  epi sodes 
of cellulitis in your patient. You encourage 
compression bandaging of his lower 
legs and organise community  nursing 
to deliver this care. You note that he has 
tinea between the toes and treat this to 
re-establish the skin barrier. 
You note that if the cellulitis recurs then 
you would need to consider other dif-
ferential diagnoses (Box 2). If recurrent 
 cellulitis is confirmed then you would 
 consider  prescribing prophylactic phen-
oxy methyl penicillin, as this has been 
shown to reduce the recurrence of cellulitis.9 
You also consider treating any recurrences 
with anti biotics delivered in the commu-
nity when safe (e.g. hospital in the home), 
to prevent future hospital admissions and 
improve patient satisfaction.10,11 
Conclusion
Most patients with soft tissue infections 
can be managed in the community. How-
ever, patients can present with sepsis, 
deeper infection and occasionally toxic 
shock syndrome. Patients with systemic 
symptoms and those who are not respond-
ing to oral antibiotics after 48 hours 
should be considered for intravenous 
antibiotic therapy.1 Patients with sepsis, 
features suggestive of necrotising fasciitis 
or toxic shock syndrome should be trans-
ferred to hospital as these conditions are 
life-threatening emergencies.   MT
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2. DIFFERENTIAL DIAGNOSES IN
PATIENTS PRESENTING WITH LEG
SWELLING AND ERYTHEMA
• Chronic venous insufficiency
• Dermatitis
• gout
• Lymphoedema
• Vasculitis
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